儿童期全身性癫痫发作

Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):512-21. 摘要

Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):522-30.全文  摘要

Eriksson KJ, Koivikko MJ. Prevalence, classification, and severity of epilepsy and epileptic syndromes in children. Epilepsia. 1997;38:1275-1282. 摘要

Kossoff EH, Zupec-Kania BA, Amark PE, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2009 Feb;50(2):304-17.全文  摘要

Nordli DR Jr. Idiopathic generalized epilepsies recognized by the International League Against Epilepsy. Epilepsia. 2005;46(suppl 9):48-56.全文  摘要

1. Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):512-21. 摘要

2. Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):522-30.全文  摘要

3. Eriksson KJ, Koivikko MJ. Prevalence, classification, and severity of epilepsy and epileptic syndromes in children. Epilepsia. 1997;38:1275-1282. 摘要

4. Hauser WA. The prevalence and incidence of convulsive disorders in children. Epilepsia. 1994;35(suppl 2):S1-S6. 摘要

5. Hauser WA, Hesdorffer DC. Epilepsy: frequency, causes, and consequences. New York, NY: Demos; 1990:18-21.

6. Camfield CS, Camfield PR, Gordon K, et al. Incidence of epilepsy in childhood and adolescents: a population-based study in Nova Scotia from 1977 to 1985. Epilepsia. 1996;37:19-23. 摘要

7. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993 May-Jun;34(3):453-68. 摘要

8. Berg AT. Risk of recurrence after a first unprovoked seizure. Epilepsia. 2008;49 Suppl 1:13-8. 摘要

9. Ramos Lizana J, Cassinello Garcia E, Carrasco Marina LL, et al. Seizure recurrence after a first unprovoked seizure in childhood: a prospective study. Epilepsia. 2000;41:1005-1013. 摘要

10. Gardiner M. Genetics of idiopathic generalized epilepsies. Epilepsia. 2005;4(suppl 9):15-20.全文  摘要

11. Weber YG, Lerche H. Genetic mechanisms in idiopathic epilepsies. Dev Med Child Neurol. 2008 Sep;50(9):648-54. 摘要

12. Nakayama J, Arinami T. Molecular genetics of febrile seizures. Epilepsy Res. 2006 Aug;70(suppl 1):S190-8. 摘要

13. Kramer MA, Cash SS. Epilepsy as a disorder of cortical network organization. Neuroscientist. 2012 Aug;18(4):360-72.全文  摘要

14. Destexhe A, McCormick DA, Sejnowski TJ. Thalamic and thalamocortical mechanisms underlying 3 Hz spike-and-wave discharges. Prog Brain Res. 1999;121:289-307. 摘要

15. Robinson R, Gardiner M. Genetics of childhood epilepsy. Arch Dis Child. 2000 Feb;82(2):121-5.全文  摘要

16. Daoud AS, Batieha A, Bashtawi M, et al. Risk factors for childhood epilepsy: a case-control study from Irbid, Jordan. Seizure. 2003 Apr;12(3):171-4. 摘要

17. Caravale B, Allemand F, Libenson MH. Factors predictive of seizures and neurologic outcome in perinatal depression. Pediatr Neurol. 2003 Jul;29(1):18-25. 摘要

18. Appleton RE, Demellweek C. Post-traumatic epilepsy in children requiring inpatient rehabilitation following head injury. J Neurol Neurosurg Psychiatry. 2002 May;72(5):669-72.全文  摘要

19. Giovanardi Rossi P, Posar A, Parmeggiani A. Epilepsy in adolescents and young adults with autistic disorder. Brain Dev. 2000 Mar;22(2):102-6. 摘要

20. Steffenburg S, Steffenburg U, Gillberg C. Autism spectrum disorders in children with active epilepsy and learning disability: comorbidity, pre- and perinatal background, and seizure characteristics. Dev Med Child Neurol. 2003 Nov;45(11):724-30. 摘要

21. Vestergaard M, Pedersen CB, Sidenius P, et al. The long-term risk of epilepsy after febrile seizures in susceptible subgroups. Am J Epidemiol. 2007 Apr 15;165(8):911-8.全文  摘要

22. Wallace SJ. Febrile seizures. In: Wallace SJ, Farrell K, eds. Epilepsy in children, 2nd ed. London, UK: Arnold; 2004:123.

23. Berg AT, Shinnar S, Levy SR, et al. Childhood-onset epilepsy with and without preceding febrile seizures. Neurology. 1999 Nov 10;53(8):1742-8. 摘要

24. Waruiru C, Appleton R. Febrile seizures: an update. Arch Dis Child. 2004 Aug;89(8):751-6.全文  摘要

25. Panayiotopoulos CP. A clinical guide to epileptic syndromes and their treatment. 2nd ed. London, UK: Springer; 2007.

26. Lu Y, Waltz S, Stenzel K, et al. Photosensitivity in epileptic syndromes of childhood and adolescence. Epileptic Disord. 2008 Jun;10(2):136-43. 摘要

27. Stephani U. The natural history of myoclonic astatic epilepsy (Doose syndrome) and Lennox-Gastaut syndrome. Epilepsia. 2006;47(suppl 2):53-5.全文  摘要

28. Pressler R, Binnie CD, Cooper R, et al, eds. Neonatal and paediatric clinical neurophysiology. Edinburgh, UK: Churchill Livingstone; 2007.

29. Winckler MI, Rotta NT. Clinical and electroencephalographic follow-up after a first unprovoked seizure. Pediatr Neurol. 2004 Mar;30(3):201-6. 摘要

30. Ohtahara S, Yamatogi Y. Ohtahara syndrome: with special reference to its developmental aspects for differentiating from early myoclonic encephalopathy. Epilepsy Res. 2006 Aug;70(suppl 1):S58-67. 摘要

31. Crespel A, Gelisse P, Bureau M, et al. Atlas of electroencephalography volume 2: the epilepsies, EEG and epileptic syndromes. Montrouge, France: John Libbey Eurotext; 2006.

32. Joshi CN, Patrick J. Eyelid myoclonia with absences: routine EEG is sufficient to make a diagnosis. Seizure. 2007 Apr;16(3):254-60. 摘要

33. Koutroumanidis M, Aggelakis K, Panayiotopoulos CP. Idiopathic epilepsy with generalized tonic-clonic seizures only versus idiopathic epilepsy with phantom absences and generalized tonic-clonic seizures: one or two syndromes? Epilepsia. 2008 Dec;49(12):2050-62. 摘要

34. Cross JH. Pitfalls in the diagnosis and differential diagnosis of epilepsy. Paediatr Child Health. 2009;19:199-202.

35. Lai V, Mak HK, Yung AW, et al. Neuroimaging techniques in epilepsy. Hong Kong Med J. 2010 Aug;16(4):292-8.全文  摘要

36. Bhatia MS. Pseudoseizures. Indian Pediatr. 2004;41:673-679.全文  摘要

37. National Institute for Health and Care Excellence. Epilepsies in children, young people and adults. Apr 2022 [internet publication].全文

38. Dwivedi R, Ramanujam B, Chandra PS, et al. Surgery for drug-resistant epilepsy in children. N Engl J Med. 2017 Oct 26;377(17):1639-47.全文  摘要

39. Hirtz D, Berg A, Bettis D, et al. Practice parameter: treatment of the child with a first unprovoked seizure. Neurology. 2003 Jan 28;60(2):166-75.全文  摘要

40. Guerrini R, Zaccara G, la Marca G, et al. Safety and tolerability of antiepileptic drug treatment in children with epilepsy. Drug Saf. 2012 Jul 1;35(7):519-33. 摘要

41. Verrotti A, Loiacono G, Coppola G, et al. Pharmacotherapy for children and adolescents with epilepsy. Expert Opin Pharmacother. 2011 Feb;12(2):175-94. 摘要

42. Rosenow F, Schade-Brittinger C, Burchardi N, et al; LaLiMo Study Group. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy - an open-label, prospective, randomised controlled multicenter study. J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1093-8. 摘要

43. Nevitt SJ, Sudell M, Weston J, et al. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev. 2017;(6):CD011412.全文  摘要

44. French JA, Krauss GL, Wechsler RT, et al. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy: a randomized trial. Neurology. 2015 Sep 15;85(11):950-7.全文  摘要

45. Robinson R. Vagal nerve stimulation is more effective than trials of further anti-epileptic drugs (AEDs) in children who have already tried >5 AEDs. Eur J Paediatr Neurol. 2011;15(suppl 1):89.

46. Englot DJ, Chang EF, Auguste KI. Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. J Neurosurg. 2011 Dec;115(6):1248-55. 摘要

47. Martin-McGill KJ, Jackson CF, Bresnahan R, et al. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev. 2018 Nov 7;11:CD001903.全文  摘要

48. European Medicines Agency. New measures to avoid valproate exposure in pregnancy endorsed. EMA/145600/2018. March 2018 [internet publication].全文

49. Medicines and Healthcare products Regulatory Agency. Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review. Jan 2021 [internet publication].全文

50. McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. 2005 Jul 16-22;366(9481):205-10. 摘要

51. Holsti M, Sill BL, Firth SD, et al. Prehospital intranasal midazolam for the treatment of pediatric seizures. Pediatr Emerg Care. 2007 Mar;23(3):148-53. 摘要

52. Holsti M, Dudley N, Schunk J, et al. Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med. 2010 Aug;164(8):747-53. 摘要

53. Engel J Jr; International League Against Epilepsy. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001 Jun;42(6):796-803.全文  摘要

54. Ozawa H, Kawada Y, Noma S, et al. Oral high-dose phenobarbital therapy for early infantile epileptic encephalopathy. Pediatr Neurol. 2002 Mar;26(3):222-4. 摘要

55. Ohno M, Shimotsuji Y, Abe J, et al. Zonisamide treatment of early infantile epileptic encephalopathy. Pediatr Neurol. 2000 Oct;23(4):341-4. 摘要

56. Kossoff EH, Zupec-Kania BA, Amark PE, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2009 Feb;50(2):304-17.全文  摘要

57. O'Callaghan FJ, Edwards S, Hancock E, et al. OP50 - 3017: The International Collaborative Infantile Spasms Study (ICISS) comparing hormonal therapies (prednisolone or tetracosactide depot) and vigabatrin versus hormonal therapies alone in the treatment of infantile spasms: Early clinical outcome. Eur J Paediatr Neurol. 2015 May;19(suppl 1):S16–17.

58. Nelson GR. Management of infantile spasms. Transl Pediatr. 2015 Oct;4(4):260-70.全文  摘要

59. Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev. 2013;(6):CD001770.全文  摘要

60. Glaze DG, Hrachovy RA, Frost JD Jr, et al. Prospective study of outcome of infants with infantile spasms treated during controlled studies of ACTH and prednisone. J Pediatr. 1988 Mar;112(3):389-96. 摘要

61. Baram TZ, Mitchell WG, Tournay A, et al. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics. 1996 Mar;97(3):375-9. 摘要

62. Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet. 2004 Nov 13-19;364(9447):1773-8. 摘要

63. Zou LP, Ding CH, Fang F, et al. Prospective study of first-choice topiramate therapy in newly diagnosed infantile spasms. Clin Neuropharmacol. 2006 Nov-Dec;29(6):343-9. 摘要

64. Korinthenberg R, Schreiner A. Topiramate in children with West syndrome: a retrospective multicenter evaluation of 100 patients. J Child Neurol. 2007 Mar;22(3):302-6. 摘要

65. Suzuki Y, Imai K, Toribe Y, et al. Long-term response to zonisamide in patients with West syndrome. Neurology. 2002 May 28;58(10):1556-9. 摘要

66. Kluger G, Zsoter A, Holthausen H. Long-term use of zonisamide in refractory childhood-onset epilepsy. Eur J Paediatr Neurol. 2008 Jan;12(1):19-23. 摘要

67. Hartman AL, Vining EP. Clinical aspects of the ketogenic diet. Epilepsia. 2007 Jan;48(1):31-42.全文  摘要

68. Auvin S, Pandit F, De Bellecize J, et al. Benign myoclonic epilepsy in infants: electroclinical features and long-term follow-up of 34 patients. Epilepsia. 2006 Feb;47(2):387-93.全文  摘要

69. Oguni H. Symptomatic epilepsies imitating idiopathic generalized epilepsies. Epilepsia. 2005;46(suppl 9):84-90.全文  摘要

70. Nordli DR Jr. Idiopathic generalized epilepsies recognized by the International League Against Epilepsy. Epilepsia. 2005;46(suppl 9):48-56.全文  摘要

71. Kassai B, Chiron C, Augier S, et al. Severe myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data. Epilepsia. 2008 Feb;49(2):343-8. 摘要

72. Chiron C, Marchand MC, Tran A, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. Lancet. 2000 Nov 11;356(9242):1638-42. 摘要

73. Brigo F, Igwe SC, Bragazzi NL. Antiepileptic drugs for the treatment of severe myoclonic epilepsy in infancy. Cochrane Database Syst Rev. 2017;(5):CD010483.全文  摘要

74. Nieto-Barrera M, Candau R, Nieto-Jimenez M, et al. Topiramate in the treatment of severe myoclonic epilepsy in infancy. Seizure. 2000 Dec;9(8):590-4. 摘要

75. Guerrini R, Dravet C, Genton P, et al. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia. 1998 May;39(5):508-12. 摘要

76. Crespel A, Genton P, Berramdane M, et al. Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology. 2005 Sep 13;65(5):762-4. 摘要

77. Dalic L, Mullen SA, Roulet Perez E, et al. Lamotrigine can be beneficial in patients with Dravet syndrome. Dev Med Child Neurol. 2015 Feb;57(2):200-2.全文  摘要

78. Caraballo RH, Cersosimo RO, Sakr D, et al. Ketogenic diet in patients with Dravet syndrome. Epilepsia. 2005 Sep;46(9):1539-44.全文  摘要

79. Kilaru S, Bergqvist AG. Current treatment of myoclonic astatic epilepsy: clinical experience at the Children's Hospital of Philadelphia. Epilepsia. 2007 Sep;48(9):1703-07.全文  摘要

80. Oguni H, Tanaka T, Hayashi K, et al. Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics. 2002 Jun;33(3):122-32. 摘要

81. Sachdeo RC, Glauser TA, Ritter F, et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Neurology. 1999 Jun 10;52(9):1882-7. 摘要

82. Motte J, Trevathan E, Arvidsson JF, et al; Lamictal Lennox-Gastaut Study Group. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med. 1997 Dec 18;337(25):1807-12.全文  摘要

83. The Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med. 1993 Jan 7;328(1):29-33.全文  摘要

84. Dodson WE. Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial. Epilepsia. 1993;34(suppl 7):S18-24. 摘要

85. Hancock EC, Cross JH. Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev. 2013;(2):CD003277.全文  摘要

86. Wier HA, Cerna A, So TY. Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview. Pediatr Drugs. 2011 Apr 1;13(2):97-106. 摘要

87. Kim SH, Eun SH, Kang HC, et al. Rufinamide as an adjuvant treatment in children with Lennox-Gastaut syndrome. Seizure. 2012 May;21(4):288-91. 摘要

88. Leahy JT, Chu-Shore CJ, Fisher JL. Clobazam as an adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome. Neuropsychiatr Dis Treat. 2011;7:673-81.全文  摘要

89. Panayiotopoulos CP. Typical absence seizures and their treatment. Arch Dis Child. 1999 Oct;81(4):351-5.全文  摘要

90. Coppola G, Auricchio G, Federico R, et al. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Epilepsia. 2004 Sep;45(9):1049-53.全文  摘要

91. Trudeau V, Myers S, LaMoreaux L, et al. Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies. J Child Neurol. 1996 Nov;11(6):470-5. 摘要

92. Kostov H, Larsson PG, Roste GK. Is vagus nerve stimulation a treatment option for patients with drug-resistant idiopathic generalized epilepsy? Acta Neurol Scand Suppl. 2007;187:55-8. 摘要

93. Covanis A, Gupta AK, Jeavons PM. Sodium valproate: monotherapy and polytherapy. Epilepsia. 1982 Dec;23(6):693-720. 摘要

94. Trevathan E, Kerls SP, Hammer AE, et al. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Pediatrics. 2006 Aug;118(2):e371-8. 摘要

95. Tennis P, Eldridge RR; International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Preliminary results on pregnancy outcomes in women using lamotrigine. Epilepsia. 2002 Oct;43(10):1161-7.全文  摘要

96. Berkovic SF, Knowlton RC, Leroy RF, et al; Levetiracetam N01057 Study Group. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology. 2007 Oct 30;69(18):1751-60. 摘要

97. Sharpe DV, Patel AD, Abou-Khalil B, et al. Levetiracetam monotherapy in juvenile myoclonic epilepsy. Seizure. 2008 Jan;17(1):64-8. 摘要

98. Verrotti A, Cerminara C, Coppola G, et al. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents. Dev Med Child Neurol. 2008 Jan;50(1):29-32. 摘要

99. Marson AG, Al-Kharusi AM, Alwaidh M, et al; SANAD Study group. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007 Mar 24;369(9566):1016-26.全文  摘要

100. Wirrell E, Camfield C, Camfield P, et al. Prognostic significance of failure of the initial antiepileptic drug in children with absence epilepsy. Epilepsia. 2001 Jun;42(6):760-3. 摘要

101. Biton V, Montouris GD, Ritter F, et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology. 1999 Apr 22;52(7):1330-7. 摘要

102. Wheless JW. Use of topiramate in childhood generalized seizure disorders. J Child Neurol. 2000;15(suppl 1):S7-13. 摘要

103. Wheless JW, Neto W, Wang S; EPMN-105 Study Group. Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy. J Child Neurol. 2004 Feb;19(2):135-41. 摘要

104. Mehta V, Ferrie CD, Cross JH, et al. Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms. Cochrane Database Syst Rev. 2015;(6):CD005222.全文  摘要

105. Gloss D, Pargeon K, Pack A, et al. Antiseizure medication withdrawal in seizure-free patients: practice advisory update summary: report of the AAN guideline subcommittee. Neurology. 2021 Dec 7;97(23):1072-81.全文  摘要

106. Panayiotopoulos CP. The epilepsies: seizures, syndromes and management. Oxford, UK: Bladon Medical Publishing; 2005:105.

107. Henderson CB, Filloux FM, Alder SC, et al. Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis. J Child Neurol. 2006 Mar;21(3):193-8. 摘要

108. Morris GL 3rd, Gloss D, Buchhalter J, et al. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy. Neurology. 2013 Oct 15;81(16):1453-9.全文  摘要

109. Wallace SJ. Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide. Epilepsy Res. 1998 Jan;29(2):147-54. 摘要

110. Tjia-Leong E, Leong K, Marson AG. Lamotrigine adjunctive therapy for refractory generalized tonic-clonic seizures. Cochrane Database Syst Rev. 2010;(12):CD007783.全文  摘要

111. Devinsky O, Patel AD, Cross JH, et al. Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome. N Engl J Med. 2018 May 17;378(20):1888-97.全文  摘要

112. Miller I, Scheffer IE, Gunning B, et al. Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in Dravet syndrome: a randomized clinical trial. JAMA Neurol. 2020 May 1;77(5):613-21.全文  摘要

113. Hogan RE, Gidal BE, Koplowitz B, et al. Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteers. Epilepsia. 2020 Mar;61(3):455-64.全文  摘要

114. Lagae L, Sullivan J, Knupp K, et al. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial. Lancet. 2020 Dec 21;394(10216):2243-54. 摘要

115. Nabbout R, Mistry A, Zuberi S, et al. Fenfluramine for treatment-resistant seizures in patients with Dravet syndrome receiving stiripentol-inclusive regimens: a randomized clinical trial. JAMA Neurol. 2019 Dec 2 [Epub ahead of print].全文  摘要

116. Knupp KG, Scheffer IE, Ceulemans B, et al. Efficacy and safety of fenfluramine for the treatment of seizures associated with ennox-Gastaut syndrome: a randomized clinical trial. JAMA Neurol. 2022 May 2 [Epub ahead of print].全文  摘要

117. Hauser E, Freilinger M, Seidl R, et al. Prognosis of childhood epilepsy in newly referred patients. J Child Neurol. 1996;11:201-204. 摘要

118. Sillanpää M, Schmidt D. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain. 2006;129:617-624.全文  摘要

119. Leone MA, Solari A, Beghi E; FIRST Group. Treatment of the first tonic-clonic seizure does not affect long-term remission of epilepsy. Neurology. 2006;67:2227-2229. 摘要

120. Beghi E, Leone M, Vallalta R, et al. Long-term mortality after a first unprovoked tonic-clonic seizure: risk factors and treatment effects. Oral presentations, abstract O6. Regional North American Annual Meeting of the World Federation of Neurology - Research Group on Neuroepidemiology, Toronto; 2010. Neuroepidemiology. 2010;34:274.全文

121. Mitchell WG. Status epilepticus and acute serial seizures in children. J Child Neurol. 2002 Jan;17 Suppl 1:S36-43. 摘要

122. Sofou K, Kristjánsdóttir R, Papachatzakis NE, et al. Management of prolonged seizures and status epilepticus in childhood: a systematic review. J Child Neurol. 2009 Aug;24(8):918-26. 摘要

123. Neville BG, Chin RF, Scott RC. Childhood convulsive status epilepticus: epidemiology, management and outcome. Acta Neurol Scand Suppl. 2007;186:21-4. 摘要

124. Shorvon S. The management of status epilepticus. J Neurol Neurosurg Psychiatry. 2001 Jun;70 Suppl 2:II22-7.全文  摘要

125. Harden C, Tomson T, Gloss D, et al; American Academy of Neurology, American Epilepsy Society. Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors. Neurology. 2017 Apr 25;88(17):1674-80.全文  摘要

126. da Costa CRCM, Maia Filho HS, Gomes MM. Clinical and neuropsychological evaluation of attention in children and adolescents with epilepsy: a systematic review [in Portuguese]. J Epilepsy Clin Neurophysiol. 2009;15(2):77-82.全文

127. Cheng LS, Prasad AN, Rieder MJ. Relationship between antiepileptic drugs and biological markers affecting long-term cardiovascular function in children and adolescents. Can J Clin Pharmacol. 2010 Winter;17(1):e5-46. 摘要

128. Fleeman N, Bradley PM, Panebianco M, et al. Care delivery and self-management strategies for children with epilepsy. Cochrane Database Syst Rev. 2022 Apr 27;4:CD006245.全文  摘要

129. Fleeman N, Bradley PM. Care delivery and self-management strategies for children with epilepsy. Cochrane Database Syst Rev. 2018;(3):CD006245.全文  摘要